Cargando…

Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI

Parkinson’s disease is characterized by neurodegeneration of the dopaminergic neurons in the substantia nigra pars compacta. The 6-hydroxydopamine (6-OHDA) rat model has been used to study neurodegeneration in the nigro-striatal dopaminergic system. The goal of this study was to evaluate the reliabi...

Descripción completa

Detalles Bibliográficos
Autores principales: Perlbarg, Vincent, Lambert, Justine, Butler, Benjamin, Felfli, Mehdi, Valabrègue, Romain, Privat, Anne-Laure, Lehéricy, Stéphane, Petiet, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126820/
https://www.ncbi.nlm.nih.gov/pubmed/30188909
http://dx.doi.org/10.1371/journal.pone.0202597
_version_ 1783353374556553216
author Perlbarg, Vincent
Lambert, Justine
Butler, Benjamin
Felfli, Mehdi
Valabrègue, Romain
Privat, Anne-Laure
Lehéricy, Stéphane
Petiet, Alexandra
author_facet Perlbarg, Vincent
Lambert, Justine
Butler, Benjamin
Felfli, Mehdi
Valabrègue, Romain
Privat, Anne-Laure
Lehéricy, Stéphane
Petiet, Alexandra
author_sort Perlbarg, Vincent
collection PubMed
description Parkinson’s disease is characterized by neurodegeneration of the dopaminergic neurons in the substantia nigra pars compacta. The 6-hydroxydopamine (6-OHDA) rat model has been used to study neurodegeneration in the nigro-striatal dopaminergic system. The goal of this study was to evaluate the reliability of diffusion MRI and resting-state functional MRI biomarkers in monitoring neurodegeneration in the 6-OHDA rat model assessed by quantitative histology. We performed a unilateral injection of 6-OHDA in the striatum of Sprague Dawley rats to produce retrograde degeneration of the dopamine neurons in the substantia nigra pars compacta. We carried out a longitudinal study with a multi-modal approach combining structural and functional MRI together with quantitative histological validation to follow the effects of the lesion. Functional and structural connectivity were assessed in the brain of 6-OHDA rats and sham rats (NaCl injection) at 3 and 6 weeks post-lesioning using resting-state functional MRI and diffusion-weighted. Our results showed (i) increased functional connectivity in ipsi- and contra-lesioned regions of the cortico-basal ganglia network pathway including the motor cortex, the globus pallidus, and the striatum regions at 3 weeks; (ii) increased fractional anisotropy (FA) in the ipsi- and contralateral striatum of the 6-OHDA group at 3 weeks, and increased axial diffusivity (AD) and mean diffusivity in the ipsilateral striatum at 6 weeks; (iii) a trend for increased FA in both substantia nigra of the 6-OHDA group at 3 weeks. Optical density measurements of tyrosine-hydroxylase (TH) staining of the striatum showed good correlations with the FA and AD measurements in the striatum. No correlations were found between the number of TH-stained dopaminergic neurons and MRI measurements in the substantia nigra. This study suggested that (i) FA and AD were reliable biomarkers to evaluate neurodegeneration in the cortico-basal ganglia network of the 6-OHDA model, (ii) diffusion MRI and resting-state functional MRI (rsfMRI) were not sensitive enough to detect changes in the substantia nigra in this model.
format Online
Article
Text
id pubmed-6126820
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-61268202018-09-15 Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI Perlbarg, Vincent Lambert, Justine Butler, Benjamin Felfli, Mehdi Valabrègue, Romain Privat, Anne-Laure Lehéricy, Stéphane Petiet, Alexandra PLoS One Research Article Parkinson’s disease is characterized by neurodegeneration of the dopaminergic neurons in the substantia nigra pars compacta. The 6-hydroxydopamine (6-OHDA) rat model has been used to study neurodegeneration in the nigro-striatal dopaminergic system. The goal of this study was to evaluate the reliability of diffusion MRI and resting-state functional MRI biomarkers in monitoring neurodegeneration in the 6-OHDA rat model assessed by quantitative histology. We performed a unilateral injection of 6-OHDA in the striatum of Sprague Dawley rats to produce retrograde degeneration of the dopamine neurons in the substantia nigra pars compacta. We carried out a longitudinal study with a multi-modal approach combining structural and functional MRI together with quantitative histological validation to follow the effects of the lesion. Functional and structural connectivity were assessed in the brain of 6-OHDA rats and sham rats (NaCl injection) at 3 and 6 weeks post-lesioning using resting-state functional MRI and diffusion-weighted. Our results showed (i) increased functional connectivity in ipsi- and contra-lesioned regions of the cortico-basal ganglia network pathway including the motor cortex, the globus pallidus, and the striatum regions at 3 weeks; (ii) increased fractional anisotropy (FA) in the ipsi- and contralateral striatum of the 6-OHDA group at 3 weeks, and increased axial diffusivity (AD) and mean diffusivity in the ipsilateral striatum at 6 weeks; (iii) a trend for increased FA in both substantia nigra of the 6-OHDA group at 3 weeks. Optical density measurements of tyrosine-hydroxylase (TH) staining of the striatum showed good correlations with the FA and AD measurements in the striatum. No correlations were found between the number of TH-stained dopaminergic neurons and MRI measurements in the substantia nigra. This study suggested that (i) FA and AD were reliable biomarkers to evaluate neurodegeneration in the cortico-basal ganglia network of the 6-OHDA model, (ii) diffusion MRI and resting-state functional MRI (rsfMRI) were not sensitive enough to detect changes in the substantia nigra in this model. Public Library of Science 2018-09-06 /pmc/articles/PMC6126820/ /pubmed/30188909 http://dx.doi.org/10.1371/journal.pone.0202597 Text en © 2018 Perlbarg et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Perlbarg, Vincent
Lambert, Justine
Butler, Benjamin
Felfli, Mehdi
Valabrègue, Romain
Privat, Anne-Laure
Lehéricy, Stéphane
Petiet, Alexandra
Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI
title Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI
title_full Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI
title_fullStr Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI
title_full_unstemmed Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI
title_short Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI
title_sort alterations of the nigrostriatal pathway in a 6-ohda rat model of parkinson’s disease evaluated with multimodal mri
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126820/
https://www.ncbi.nlm.nih.gov/pubmed/30188909
http://dx.doi.org/10.1371/journal.pone.0202597
work_keys_str_mv AT perlbargvincent alterationsofthenigrostriatalpathwayina6ohdaratmodelofparkinsonsdiseaseevaluatedwithmultimodalmri
AT lambertjustine alterationsofthenigrostriatalpathwayina6ohdaratmodelofparkinsonsdiseaseevaluatedwithmultimodalmri
AT butlerbenjamin alterationsofthenigrostriatalpathwayina6ohdaratmodelofparkinsonsdiseaseevaluatedwithmultimodalmri
AT felflimehdi alterationsofthenigrostriatalpathwayina6ohdaratmodelofparkinsonsdiseaseevaluatedwithmultimodalmri
AT valabregueromain alterationsofthenigrostriatalpathwayina6ohdaratmodelofparkinsonsdiseaseevaluatedwithmultimodalmri
AT privatannelaure alterationsofthenigrostriatalpathwayina6ohdaratmodelofparkinsonsdiseaseevaluatedwithmultimodalmri
AT lehericystephane alterationsofthenigrostriatalpathwayina6ohdaratmodelofparkinsonsdiseaseevaluatedwithmultimodalmri
AT petietalexandra alterationsofthenigrostriatalpathwayina6ohdaratmodelofparkinsonsdiseaseevaluatedwithmultimodalmri